(Q40937374)

25 September 2017

title

Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells (English)

1 reference

25 September 2017

1 reference

Lee TH

1

1 reference

25 September 2017

Chuang LY

series ordinal

2

1 reference

25 September 2017

Hung WC

series ordinal

3

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

18

1 reference

25 September 2017

issue

29

1 reference

25 September 2017

page(s)

4269-4274

1 reference

Mechanisms that help the yeast cell cycle clock tick: G2 cyclins transcriptionally activate G2 cyclins and repress G1 cyclins

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

p53 in signaling checkpoint arrest or apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

The pharmacology and clinical uses of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Hormonal chemoprevention of cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Translational control of p27Kip1 accumulation during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Endocrine pharmacology of antiestrogens as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Molecular mechanisms of antiestrogen action in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Tamoxifen stimulates phospholipase D activity by an estrogen receptor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Molecular cloning and characterization of the human p27Kip1 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Cyclins and cyclin-dependent kinases: take your partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Cell cycle regulation of human pancreatic cancer by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Distinct roles for cyclin-dependent kinases in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

Tamoxifen retards glycosphingolipid metabolism in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21(waf1/cip1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202755

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202755

1 reference

Dimensions Publication ID

25 September 2017

1010188936

0 references

1 reference